Cybin Inc
Change company Symbol lookup
Select an option...
CYBN Cybin Inc
AMWD American Woodmark Corp
CSWC Capital Southwest Corp
FNGR FingerMotion Inc
AMSC American Superconductor Corp
ABST Absolute Software Corp
ACAC Acri Capital Acquisition Corp
HAE Haemonetics Corp
HUIZ Huize Holding Ltd
CIG Energy of Minas Gerais Co
Go


Based in Canada
Company profile

Cybin Inc. is a Canada-based biotechnology company. The Company is focused on progressing Psychedelics to therapeutics by engineering drug discovery platforms, drug delivery systems, formulation approaches and treatment regimens for mental health disorders. Across the various research and development programs, the Company is researching and developing an array of synthetic psychedelic active pharmaceutical ingredients (API) intended to be delivered through drug delivery systems, including sublingual films1, orally disintegrating tablets (ODT)2, via inhalation and via intravenous (IV). Its drug programs include Depressive Disorder (CYB003), Alcohol Use Disorder (CYB003), Anxiety Disorders (CYB004) and Neuroinflammation (CYB005). The Company focuses on the clinical development path for CYB004, the Company's deuterated Phase 1 N,N-dimethyltryptamine (DMT) molecule, for the treatment of anxiety disorders. Its subsidiaries include Cybin Corp., Natures Journey Inc, and others.

Price
Delayed
$0.6134
Day's Change
0.0301 (5.16%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.6299
Day's Low
0.5843
Volume
(Average)

Today's volume of 577,218 shares is on pace to be in-line with CYBN's 10-day average volume of 1,153,860 shares.

577,218

Upcoming Events

CYBN's fiscal year ends in March
There are no upcoming events for CYBN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
August 8, 2022Q1 2023 Earnings Release-$0.055-$0.079 to -$0.063--
June 22, 2022Q4 2022 Earnings Release-$0.079-$0.08 to -$0.071--
February 10, 2022Q3 2022 Earnings Release-$0.08-$0.088 to -$0.072--
November 15, 2021Q2 2022 Earnings Release-$0.088-$0.11 to -$0.056--

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.